Skip to content
Quant500 - Quantitative Analysis
Search ticker or company...
ES | EN

Company Profile: CVS Health Corporation (CVS)

CVS insider trades (13 months) →

$91.41 +3.28% vs. previous close · Market cap $116.91B

Today's multi-factor rank: 29 of 461 · see the ranking

Momentum
5.1/10
Value
7.3/10
Growth
6.8/10
Quality
4.2/10
Multifactor
5.8/10

Market and Valuation

Price & Market

Prev Close Price:$88.51
Open:$88.43
Day's Low:$88.02
Day's High:$91.89
Bid / Ask:-
Market Cap:116.91B
Enterprise Value:175.75B

52-Week Range

52-Week Low:$69.51
52-Week High:$110.68
Current position in 52-week range
52w Low-52w High
50-Day Avg:$91.14
200-Day Avg:$88.82

Volume

Volume Today:19,535,816
Avg Volume (3m):8,026,064
Avg Volume (10d):6,794,170
52-Week Change:+13.36%
vs S&P 500, 52 weeks:-
Beta:0.58

Valuation Multiples

P/E (trailing):24.06

Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Aug 5, 2026. The P/E is the price divided by that EPS.

P/E (forward):10.71
PEG Ratio:0.21
Price / Book:1.47
Price / Sales (TTM):0.28
EV / Revenue:0.43
EV / EBITDA:10.54

Dividends

Current yield:3.01%
Annual Dividend Rate:$2.66
Dividend Trailing:$2.66
Yield Trailing:3.01%
5-Year Avg Yield:3.03%
Payout Ratio:70.00%
Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-
Fiscal Year (Next):-

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):412.64B
Gross Profit:56.31B
EBITDA:16.68B
Net Income (TTM):4.89B
Rev Growth (YoY):+7.10%
Earnings Growth (YoY):+188.80%
Quarterly earnings growth (YoY):+191.80%

Margins

Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-

Per Share

EPS Trailing (TTM):$3.80

Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Aug 5, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$8.54
Revenue Per Share:$324.15
Cash Per Share:-
Book Value:$62.37
Last Dividend:-
Ex-Dividend Date:-
Last Split:-

Balance Sheet & Liquidity

Total cash:13.96B
Total Debt:76.31B
Net Debt (Debt - Cash):62.35B
Debt / Equity:95.50%
Current Ratio:0.87
Quick Ratio:0.62

Cash Flows

Operating Cash Flow:14.78B
Free Cash Flow (FCF):8.08B
FCF Yield (FCF / Market Cap):-
Enterprise Value:175.75B
EV / Revenue:0.43
EV / EBITDA:10.54

Profitability

ROE (Return on Equity):6.21%
ROA (Return on Assets):2.97%
P/E (trailing):24.06
P/E (forward):10.71
Price / Book:1.47
PEG Ratio:0.21
52-Week Change:+13.36%
S&P 500 change, 52 weeks:+11.37%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$3.80

Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Aug 5, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$8.54
P/E (forward):10.71
PEG Ratio:0.21

Growth and Margins

Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-

Per Share

Revenue Per Share:$324.15
Cash Per Share:-
Book Value:$62.37

Cash Flows (TTM)

Free Cash Flow:8.08B
Operating Cash Flow:14.78B
EBITDA:16.68B
Total Revenue (TTM):412.64B
Net Income (TTM):4.89B
Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter Period Actual EPS Estimated EPS Difference Surprise % Currency

Ownership Structure

Ownership Distribution

% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:1,278,970,369
Float (free shares):1,276,450,797
Short interest (shares):16,193,404
Short % of float:-
Short Ratio (days to cover):1.63
Short interest, prior month:-
Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization Report Date % Shares No. Shares Value (USD) Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund Report Date % Shares No. Shares Value (USD) Change %

Recent Insider Trades

Executive / Insider Title Date Action Shares

Options Chain

CALLS

StrikeLastBidAskVol.O.I.IV

PUTS

StrikeLastBidAskVol.O.I.IV

CVS Health Corporation (CVS) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type Date Official link
8-K2026-08-17View filing ↗
8-K2026-08-05View filing ↗
11-K2026-06-23View filing ↗
S-82026-05-22View filing ↗
8-K2026-05-18View filing ↗
10-Q2026-05-06View filing ↗
DEF 14A2026-04-03View filing ↗
8-K2026-03-19View filing ↗
10-K2026-02-10View filing ↗
8-K2025-12-09View filing ↗

Company and Executive Profile

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

General Information

Headquarters:United States
City:Woonsocket
Employees:219,000
Sector:Healthcare
Industry:Healthcare Plans
Website:-

Key Executives

NameTitleAgeTotal pay
Mr. J. David Joyner CEBSCEO, President & Chairman606.65M
Mr. Brian O. NewmanExecutive VP & CFO562.82M
Mr. Tilak MandadiEVP of Ventures and Chief Experience & Technology Officer613.98M
Mr. Prem S. Shah Pharm.DExecutive VP & Group President454.38M
Mr. Steven Hale Nelson M.B.A.Executive VP & President of Aetna664.34M
Mr. James David ClarkSenior VP, Controller & Chief Accounting Officer60-
Mr. David A. FalkowskiExecutive VP & Chief Compliance Officer--
Mr. Samrat S. Khichi Esq.Executive VP of Corporate Affairs & Chief Legal Officer583.39M

You have seen the engine room

A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.

No card. No spam.

CVS Health Corporation (CVS): Quantitative Analysis

CVS Health Corporation (CVS) — Healthcare — Healthcare Plans. CVS is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, CVS has returned +18.5% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.

CVS ranks 29 of 461 on today's multifactor score, and 1 of the 55 Healthcare companies that score. Its strongest factor is value (Z 1.40, ranked 22 of 489); its weakest is quality (Z -0.51, ranked 391 of 468). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

FactorZ-ScoreRank
Multifactor0.50929 of 461 ↓2
Momentum0.045212 of 494 ↓14
Value1.39522 of 489 ↓3
Quality-0.509391 of 468 ↓1
Growth1.10435 of 489

Market data

MetricValue
Price$91.41
Market Cap116.91B
P/E24.06
Revenue (last 12 months)412.64B
Price / book1.47
Book value per share$62.37
52-week range$69.51 – $110.68
Dividend yield3.01%
Beta0.58
Average volume8,026,064
Shares outstanding1.28B
Short interest (% of float)1.28% (as of Oct 15, 2026)

When does CVS report earnings? 12 of its last 12, before the open →

What are CVS insiders doing? 54 transactions filed with the SEC, of them 4 buys and 5 sells, the last one on Jun 26, 2026 →

CVS latest SEC filings

Filing dates on EDGAR, the SEC's public registry. All CVS filings on EDGAR.

Guides: How to read a Quant500 company page · What the S&P 500 is · P/E ratio explained · 10-K, 10-Q and 8-K · all guides

Frequently asked questions about CVS Health (CVS)

When does CVS Health report earnings?

According to Nasdaq's public calendar (checked on Nov 4, 2026), CVS Health will report its next earnings on Nov 4, 2026, before the US market opens. The date is announced by the company itself and can change. Of its last 12 earnings announcements: 12 before the open (SEC filings through Aug 5, 2026). CVS earnings dates and times, quarter by quarter →

What is CVS Health's P/E ratio?

CVS Health's P/E (price over earnings per share for the last twelve months) is 24.1 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Jun 30, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: CVS Health is below its sector median. Healthcare stocks, company by company →

Where does CVS Health rank on Quant500?

In the Nov 3, 2026 multi-factor ranking, CVS Health ranks 29 of 461, and 1 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking → How it is calculated →

Have CVS Health insiders bought or sold shares?

The latest open-market purchase of CVS Health shares filed with the SEC (Form 4) was on Jan 23, 2025, by an officer, for $1k. The latest sale was on May 21, 2026, by a director, for $34.6M. In total, from August 2025 through Nov 3, 2026: 4 purchases and 5 sales by directors, officers and large shareholders. All CVS insider trades →

Does CVS Health pay a dividend?

Yes. Its dividend yield is 3.01% at the Nov 3, 2026 close (annual dividend of $2.66 per share). The latest recorded ex-dividend date is Oct 22, 2026.

What sector is CVS Health in, and which index?

CVS Health is classified in the Healthcare sector (industry: Healthcare Plans), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →

What is behind these numbers

The concepts on this page, explained from scratch in the Academy. Free, no account.

The whole Academy, course by course →

Data as of Nov 3, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

The model portfolio, weekly in your inbox

Every Saturday, its week in one minute: how it went, the best and the worst, and which insiders bought with their own money. Plus, the day the model is rebuilt, which stocks come in and which go out. A simulation, not advice. At most one email a week, no ads, no account; one-click unsubscribe. Made by one person: Pol Gracia.

A model portfolio with simulated results, not a personalized recommendation. Your email is used for this only: privacy.

S&P 500 market gravity